(Q78245024)

English

Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma

scientific article published on 01 July 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482089%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482089%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

timolol maleate

1 reference

based on heuristic

inferred from title

open-angle glaucoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

A G Konstas

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482089%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

A C Maltezos

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482089%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

S Gandi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482089%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

A C Hudgins

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482089%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

W C Stewart

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482089%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

language of work or name

0 references

publication date

1 July 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482089%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

American Journal of Ophthalmology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482089%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

128

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482089%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482089%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

15-20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482089%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2 alpha-1-isopropylester in the cynomolgus monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900073-2

7 January 2021

A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900073-2

7 January 2021

A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900073-2

7 January 2021

Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900073-2

7 January 2021

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900073-2

7 January 2021

Effect of timolol on the diurnal intraocular pressure in exfoliation and primary open-angle glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900073-2

7 January 2021

Systemic side effects of topical beta-adrenergic blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2899%2900073-2

7 January 2021

Identifiers

10.1016/S0002-9394(99)00073-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482089%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482089%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q78245024&oldid=2230166972"